Q1MSW8 (Q1MSW8_HUMAN) Unreviewed, UniProtKB/TrEMBL
Last modified
April 3, 2013.
Version 57.
History...
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry infoCustomize order
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry infoCustomize orderNames and origin
| Protein names | Recommended name: Cellular tumor antigen p53 RuleBase RU003304 | ||
| Gene names |
| ||
| Organism | Homo sapiens (Human) EMBL CAJ28923.1 | ||
| Taxonomic identifier | 9606 [NCBI] | ||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 343 AA. |
| Sequence status | Fragment. |
| Protein existence | Evidence at transcript level |
General annotation (Comments)
| Function | Acts as a tumor suppressor in many tumor types; induces growth arrest or apoptosis depending on the physiological circumstances and cell type. Involved in cell cycle regulation as a trans-activator that acts to negatively regulate cell division by controlling a set of genes required for this process. One of the activated genes is an inhibitor of cyclin-dependent kinases. Apoptosis induction seems to be mediated either by stimulation of BAX and FAS antigen expression, or by repression of Bcl-2 expression By similarity. |
| Cofactor | Binds 1 zinc ion per subunit By similarity. |
| Subunit structure | Binds DNA as a homotetramer By similarity. |
| Subcellular location | |
| Sequence similarities | Belongs to the p53 family. RuleBase RU003401 |
Ontologies
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | |||
Experimental info | ||||||||
|---|---|---|---|---|---|---|---|---|
| Non-terminal residue | 1 | 1 | EMBL CAJ28923.1 | |||||
| Non-terminal residue | 343 | 1 | EMBL CAJ28923.1 | |||||
Sequences
| ||||||||||||||||||
References
| [1] | "Dysfunctional p53 deletion mutants in cell lines derived from Hodgkin's lymphoma." Feuerborn A., Moritz C., von Bonin F., Dobbelstein M., Tromper M., Strzenhofecker B., Kube D. Leuk. Lymphoma 47:1932-1940(2006) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE. Tissue: Classical Hodgkin Lymphoma EMBL CAJ28923.1. |
| [2] | "Pharmacologic activation of p53-dependent and p53-independent apoptotic pathways in Hodgkin/Reed-Sternberg cells." Janz M., Stuhmer T., Vassilev L.T., Bargou R.C. Submitted (NOV-2006) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | EF101868 mRNA. Translation: ABL09847.1. AM076972 mRNA. Translation: CAJ28923.1. |
| IPI | IPI01011775. |
| UniGene | Hs.437460. Hs.740601. |
3D structure databases | |
| ProteinModelPortal | Q1MSW8. |
| ModBase | Search... |
Protocols and materials databases | |
| StructuralBiologyKnowledgebase | Search... |
Phylogenomic databases | |
| HOVERGEN | HBG005201. |
Family and domain databases | |
| Gene3D | 2.60.40.720. 1 hit. |
| InterPro | IPR008967. p53-like_TF_DNA-bd. IPR012346. p53/RUNT-type_TF_DNA-bd. IPR011615. p53_DNA-bd. IPR013872. p53_transactivation_domain. IPR002117. p53_tumour_suppressor. [Graphical view] |
| PANTHER | PTHR11447. PTHR11447. 1 hit. |
| Pfam | PF00870. P53. 1 hit. PF08563. P53_TAD. 1 hit. [Graphical view] |
| PRINTS | PR00386. P53SUPPRESSR. |
| SUPFAM | SSF49417. P53_like_DNA_bnd. 1 hit. |
| PROSITE | PS00348. P53. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Other | |
| ChiTaRS | TP53. human. |
Entry information
| Entry name | Q1MSW8_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q1MSW8 | ||||||||
| Entry history |
| ||||||||
| Entry status | Unreviewed (UniProtKB/TrEMBL) | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||

Clusters with
